Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,328,774
-
Share change
-
+2,170,746
-
Total reported value
-
$163,545,578
-
Price per share
-
$10.67
-
Number of holders
-
44
-
Value change
-
+$24,313,229
-
Number of buys
-
21
-
Number of sells
-
19
Institutional Holders of ALPINE IMMUNE SCIENCES INC - COM (ALPN) as of Q3 2021
As of 30 Sep 2021,
ALPINE IMMUNE SCIENCES INC - COM (ALPN) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,328,774 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Omega Fund Management, LLC, Avidity Partners Management LP, FRAZIER MANAGEMENT LLC, BVF INC/IL, Artal Group S.A., VANGUARD GROUP INC, BlackRock Inc., Logos Global Management LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.